Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Nyu Langone Health Appoints Sunil Rao As Director of Cardiology and Susheel K. Kodali As Director of Interventional Cardiology

PRIVATEAug 27, 2026•about 4 hours ago

Position

Director

Company

NYU Langone Health

Susheel K. Kodali
New YorkBiotechnologyHealth CareMedicalTherapeutics

Description

NYU Langone Health has appointed Sunil Rao, MD, as director of the Leon H. Charney Division of Cardiology, and Susheel K. Kodali, MD, will take on the roles of director of interventional cardiology and director of the cardiac catheterization laboratory

Company Information

Company

NYU Langone Health

Location

New York, New York, United States

About

As a specialist in the field of cardio-oncology, Dr. Bloom focuses on early prevention, detection, treatment, and management of the potential cardiac effects of cancer treatments so that patients can safely continue their therapies. She will lead the system-wide program, which unites cardiologists, oncologists, immunologists and researchers from both NYU Langone Heart and NYU Langone's Perlmutter Cancer Center, to coordinate personalized cardiac care designed with our cancer patients in mind. Dr. Bloom and the team also offer specialized treatment to cancer survivors so that their risk of cardiovascular disease can be recognized early and minimized. Dr. Bloom has been a pioneer in the field, publishing in peer-reviewed journals on how to best provide cardio-oncology care.

Don't miss NYU Langone Health's next move

Get an email the moment NYU Langone Health changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Anne
Likely contact at this company
••••••••@••••••••

See Anne's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for NYU Langone Health's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

NYU Langone Health changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.